Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend. Results are promising: The vaccine reduces recurrence and death alongside an immunotherapy drug.
Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer
Source: NPR Health
Original reporting
NPR Health: read the full reportFollow this story
Earlier reports and follow-ups on the same developing story.
Related stories
BBC Science
Storm Boelo leaves 90,000 without power as Met Office issues new wind warning
Around 90,000 properties are without power after Scotland and north England is battered by strong winds.
BBC Science
What do we still need to know about the Tyne nurdle spill?
The spill of 18 tonnes of plastic pellets happened in July but there is still a lot we do not know.
NPR Health
Special ed diaries: Teachers tell NPR about their most joyous, most difficult moments
What makes special education teaching jobs so hard to fill? NPR set out to find some answers by talking to more than a dozen teachers who do this work every day.
NPR Health
Some people with meat allergies from alpha-gal syndrome turn to exotic alternatives
People with Alpha-Gal Syndrome can have allergic reactions to meat from mammals. Many of those affected change their diets to eat other proteins.
BBC Science
Storm Boelo clears but more wind and rain bears down on UK
Another area of low pressure will pass close to the north-west UK with a Met Office yellow wind warning issued for Tuesday.
BBC Science
Plans to create a wildflower meadow take shape
Fairstead Recreation Ground is being planted with wildflowers to benefit insects and pollinators.